Repligen shares rise 3% as Q3 revenue growth tops expectations
PositiveFinancial Markets

Repligen's shares have seen a 3% increase following a strong third-quarter revenue growth that exceeded market expectations. This positive performance highlights the company's robust business strategy and ability to adapt to market demands, making it a noteworthy player in the biotechnology sector.
— Curated by the World Pulse Now AI Editorial System











